{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T20:10:38Z","timestamp":1788120638623,"version":"build-2803163510"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yanbian Prefecture Science and Technology Development Program Project","award":["2025NS15"],"award-info":[{"award-number":["2025NS15"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-026-06471-3","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T20:57:43Z","timestamp":1776113863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Macrophage plasticity in the osteosarcoma tumor microenvironment: opportunities and challenges for immunotherapy"],"prefix":"10.1007","volume":"152","author":[{"given":"Haifeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengri","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"6471_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/292376","volume":"2014","author":"D Aldinucci","year":"2014","unstructured":"Aldinucci D, Colombatti A (2014) The inflammatory chemokine CCL5 and cancer progression. Mediators Inflamm 2014:292376","journal-title":"Mediators Inflamm"},{"issue":"2","key":"6471_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1517\/14656566.2011.543129","volume":"12","author":"K Ando","year":"2011","unstructured":"Ando K, Mori K, Corradini N, Redini F, Heymann D (2011) Mifamurtide for the treatment of nonmetastatic osteosarcoma. Expert Opin Pharmacother 12(2):285\u2013292","journal-title":"Expert Opin Pharmacother"},{"key":"6471_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010046","author":"C Anfray","year":"2019","unstructured":"Anfray C, Ummarino A, And\u00f3n FT, Allavena P (2019) Current strategies to target tumor-associated-macrophages to improve anti-tumor immune responses. Cells. https:\/\/doi.org\/10.3390\/cells9010046","journal-title":"Cells"},{"issue":"2","key":"6471_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L et al (2019) Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol 20(2):163\u2013172","journal-title":"Nat Immunol"},{"issue":"6","key":"6471_CR5","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","volume":"78","author":"JE Bader","year":"2020","unstructured":"Bader JE, Voss K, Rathmell JC (2020) Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Mol Cell 78(6):1019\u20131033","journal-title":"Mol Cell"},{"key":"6471_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26041699","author":"SH Barsky","year":"2025","unstructured":"Barsky SH, Mcphail K, Wang J, Hoffman RM, Ye Y (2025) Bone marrow origin of mammary phagocytic intraductal macrophages (foam cells). Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26041699","journal-title":"Int J Mol Sci"},{"issue":"6","key":"6471_CR7","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D (2016) Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell 30(6):836\u2013848","journal-title":"Cancer Cell"},{"issue":"1","key":"6471_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00409-y","volume":"8","author":"HC Beird","year":"2022","unstructured":"Beird HC, Bielack SS, Flanagan AM et al (2022) Osteosarcoma. Nat Rev Dis Primers 8(1):77","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"6471_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.581","volume":"12","author":"C Boibessot","year":"2022","unstructured":"Boibessot C, Molina O, Lachance G et al (2022) Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor-associated macrophage phenotype. Clin Transl Med 12(1):e581","journal-title":"Clin Transl Med"},{"issue":"7525","key":"6471_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nature13862","volume":"515","author":"L Bonapace","year":"2014","unstructured":"Bonapace L, Coissieux M, Wyckoff J et al (2014) Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature 515(7525):130\u2013133","journal-title":"Nature"},{"issue":"7986","key":"6471_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","volume":"623","author":"N Caronni","year":"2023","unstructured":"Caronni N, La Terza F, Vittoria FM et al (2023) IL-1\u03b2+ macrophages fuel pathogenic inflammation in pancreatic cancer. Nature 623(7986):415\u2013422","journal-title":"Nature"},{"issue":"2","key":"6471_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1158\/2326-6066.CIR-19-0692","volume":"8","author":"DL Casey","year":"2020","unstructured":"Casey DL, Cheung NV (2020) Immunotherapy of pediatric solid tumors: treatments at a crossroads, with an emphasis on antibodies. Cancer Immunol Res 8(2):161\u2013166","journal-title":"Cancer Immunol Res"},{"issue":"12","key":"6471_CR13","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"Cassetta L, Pollard JW (2018) Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov 17(12):887\u2013904","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"6471_CR14","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1073\/pnas.0730640100","volume":"100","author":"R Castriconi","year":"2003","unstructured":"Castriconi R, Cantoni C, Chiesa MD et al (2003) Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci U S A 100(7):4120\u20134125","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6471_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2021.100372","volume":"29","author":"X Chang","year":"2021","unstructured":"Chang X, Ma Z, Zhu G, Lu Y, Yang J (2021) New perspective into mesenchymal stem cells: molecular mechanisms regulating osteosarcoma. J Bone Oncol 29:100372","journal-title":"J Bone Oncol"},{"issue":"3","key":"6471_CR16","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s12094-018-1927-z","volume":"21","author":"P Chen","year":"2019","unstructured":"Chen P, Zhou J, Li J, Zhang Q, Zuo Q (2019) TIPE1 suppresses osteosarcoma tumor growth by regulating macrophage infiltration. Clin Transl Oncol 21(3):334\u2013341","journal-title":"Clin Transl Oncol"},{"key":"6471_CR17","volume":"2022","author":"X Chen","year":"2022","unstructured":"Chen X, Zhang N, Zheng Y et al (2022) Identification of key genes and pathways in osteosarcoma by bioinformatics analysis. Comput Math Methods Med 2022:7549894","journal-title":"Comput Math Methods Med"},{"issue":"2","key":"6471_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.arcmed.2020.10.018","volume":"52","author":"Z Cheng","year":"2021","unstructured":"Cheng Z, Wang L, Wu C, Huang L, Ruan Y, Xue W (2021) Tumor-derived exosomes induced M2 macrophage polarization and promoted the metastasis of osteosarcoma cells through Tim-3. Arch Med Res 52(2):200\u2013210","journal-title":"Arch Med Res"},{"key":"6471_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16020251","author":"S Cheng","year":"2024","unstructured":"Cheng S, Wang H, Kang X, Zhang H (2024) Immunotherapy innovations in the fight against osteosarcoma: emerging strategies and promising progress. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics16020251","journal-title":"Pharmaceutics"},{"issue":"21","key":"6471_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70387","volume":"13","author":"J Chi","year":"2024","unstructured":"Chi J, Gao Q, Liu D (2024) Tissue-resident macrophages in cancer: friend or foe. Cancer Med 13(21):e70387","journal-title":"Cancer Med"},{"key":"6471_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/genes15020197","author":"J Cornice","year":"2024","unstructured":"Cornice J, Verzella D, Arboretto P et al (2024) NF-\u03baB: governing macrophages in cancer. Genes. https:\/\/doi.org\/10.3390\/genes15020197","journal-title":"Genes"},{"issue":"11","key":"6471_CR22","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1084\/jem.20100587","volume":"207","author":"CA Corzo","year":"2010","unstructured":"Corzo CA, Condamine T, Lu L et al (2010) HIF-1\u03b1 regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med 207(11):2439\u20132453","journal-title":"J Exp Med"},{"key":"6471_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev-immunol-093019-111748","volume":"39","author":"N Cox","year":"2021","unstructured":"Cox N, Pokrovskii M, Vicario R, Geissmann F (2021) Origins, biology, and diseases of tissue macrophages. Annu Rev Immunol 39:313\u2013344","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"6471_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2013.04.034","volume":"229","author":"M Crucet","year":"2013","unstructured":"Crucet M, W\u00fcst SJA, Spielmann P, L\u00fcscher TF, Wenger RH, Matter CM (2013) Hypoxia enhances lipid uptake in macrophages: role of the scavenger receptors Lox1, SRA, and CD36. Atherosclerosis 229(1):110\u2013117","journal-title":"Atherosclerosis"},{"issue":"1","key":"6471_CR25","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1186\/s12967-025-06920-6","volume":"23","author":"C Dai","year":"2025","unstructured":"Dai C, Shen B, Liu S et al (2025) Pharmacologic inhibition of CSF-1R suppresses intrinsic tumor cell growth in osteosarcoma with CSF-1R overexpression. J Transl Med 23(1):900","journal-title":"J Transl Med"},{"issue":"7629","key":"6471_CR26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20554","volume":"539","author":"O De Henau","year":"2016","unstructured":"De Henau O, Rausch M, Winkler D et al (2016) Overcoming resistance to checkpoint blockade therapy by targeting PI3K\u03b3 in myeloid cells. Nature 539(7629):443\u2013447","journal-title":"Nature"},{"issue":"1","key":"6471_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s13193-020-01277-2","volume":"12","author":"A Dharanikota","year":"2021","unstructured":"Dharanikota A, Arjunan R, Dasappa A (2021) Factors affecting prognosis and survival in extremity osteosarcoma. Indian J Surg Oncol 12(1):199\u2013206","journal-title":"Indian J Surg Oncol"},{"issue":"19","key":"6471_CR28","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1158\/0008-5472.CAN-10-1439","volume":"70","author":"AL Doedens","year":"2010","unstructured":"Doedens AL, Stockmann C, Rubinstein MP et al (2010) Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res 70(19):7465\u20137475","journal-title":"Cancer Res"},{"issue":"8","key":"6471_CR29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong H, Strome SE, Salomao DR et al (2002) Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8(8):793\u2013800","journal-title":"Nat Med"},{"issue":"4","key":"6471_CR30","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s10637-021-01084-8","volume":"39","author":"A Dowlati","year":"2021","unstructured":"Dowlati A, Harvey RD, Carvajal RD et al (2021) LY3022855, an anti-colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial. Invest New Drugs 39(4):1057\u20131071","journal-title":"Invest New Drugs"},{"issue":"8","key":"6471_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-020-00760-w","volume":"21","author":"F Duffaud","year":"2020","unstructured":"Duffaud F (2020) Role of TKI for metastatic osteogenic sarcoma. Curr Treat Options Oncol 21(8):65","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"6471_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S1470-2045(18)30742-3","volume":"20","author":"F Duffaud","year":"2019","unstructured":"Duffaud F, Mir O, Boudou-Rouquette P et al (2019) Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study. Lancet Oncol 20(1):120\u2013133","journal-title":"Lancet Oncol"},{"issue":"2","key":"6471_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ijc.24401","volume":"125","author":"D Duluc","year":"2009","unstructured":"Duluc D, Corvaisier M, Blanchard S et al (2009) Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int J Cancer 125(2):367\u2013373","journal-title":"Int J Cancer"},{"issue":"6186","key":"6471_CR34","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.1252510","volume":"344","author":"RA Franklin","year":"2014","unstructured":"Franklin RA, Liao W, Sarkar A et al (2014) The cellular and molecular origin of tumor-associated macrophages. Science 344(6186):921\u2013925","journal-title":"Science"},{"key":"6471_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.633607","volume":"9","author":"Y Fu","year":"2021","unstructured":"Fu Y, Bao Q, Liu Z et al (2021) Development and validation of a hypoxia-associated prognostic signature related to osteosarcoma metastasis and immune infiltration. Front Cell Dev Biol 9:633607","journal-title":"Front Cell Dev Biol"},{"key":"6471_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/348539","volume":"2014","author":"Y Fujiwara","year":"2014","unstructured":"Fujiwara Y, Takeya M, Komohara Y (2014) A novel strategy for inducing the antitumor effects of triterpenoid compounds: blocking the protumoral functions of tumor-associated macrophages via STAT3 inhibition. Biomed Res Int 2014:348539","journal-title":"Biomed Res Int"},{"issue":"1","key":"6471_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0316-z","volume":"6","author":"J Gong","year":"2018","unstructured":"Gong J, Chehrazi-Raffle A, Reddi S, Salgia R (2018) Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations. J Immunother Cancer 6(1):8","journal-title":"J Immunother Cancer"},{"issue":"7655","key":"6471_CR38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon SR, Maute RL, Dulken BW et al (2017) PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545(7655):495\u2013499","journal-title":"Nature"},{"key":"6471_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020210","author":"M Haist","year":"2021","unstructured":"Haist M, Stege H, Grabbe S, Bros M (2021) The functional crosstalk between myeloid-derived suppressor cells and regulatory T cells within the immunosuppressive tumor microenvironment. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13020210","journal-title":"Cancers (Basel)"},{"key":"6471_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.intimp.2016.01.023","volume":"34","author":"Q Han","year":"2016","unstructured":"Han Q, Shi H, Liu F (2016) CD163(+) M2-type tumor-associated macrophage support the suppression of tumor-infiltrating T cells in osteosarcoma. Int Immunopharmacol 34:101\u2013106","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"6471_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.04.012","volume":"215","author":"L He","year":"2019","unstructured":"He L, Li Z (2019) B7-H3 and its role in bone cancers. Pathol Res Pract 215(6):152420","journal-title":"Pathol Res Pract"},{"key":"6471_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.741305","volume":"12","author":"Z He","year":"2021","unstructured":"He Z, Zhang S (2021) Tumor-associated macrophages and their functional transformation in the hypoxic tumor microenvironment. Front Immunol 12:741305","journal-title":"Front Immunol"},{"issue":"2","key":"6471_CR43","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3892\/ol.2016.4714","volume":"12","author":"YT He","year":"2016","unstructured":"He YT, Zhang QM, Kou QC, Tang B (2016) In vitro generation of cytotoxic T lymphocyte response using dendritic cell immunotherapy in osteosarcoma. Oncol Lett 12(2):1101\u20131106","journal-title":"Oncol Lett"},{"issue":"5","key":"6471_CR44","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1189\/jlb.3A1116-492R","volume":"101","author":"NJ Hess","year":"2017","unstructured":"Hess NJ, Felicelli C, Grage J, Tapping RI (2017) TLR10 suppresses the activation and differentiation of monocytes with effects on DC-mediated adaptive immune responses. J Leukoc Biol 101(5):1245\u20131252","journal-title":"J Leukoc Biol"},{"issue":"4","key":"6471_CR45","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12094-012-0795-1","volume":"14","author":"N Himoudi","year":"2012","unstructured":"Himoudi N, Wallace R, Parsley KL et al (2012) Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma. Clin Transl Oncol 14(4):271\u2013279","journal-title":"Clin Transl Oncol"},{"key":"6471_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.788365","volume":"11","author":"T Hourani","year":"2021","unstructured":"Hourani T, Holden JA, Li W, Lenzo JC, Hadjigol S, O\u2019Brien-Simpson NM (2021) Tumor associated macrophages: origin, recruitment, phenotypic diversity, and targeting. Front Oncol 11:788365","journal-title":"Front Oncol"},{"key":"6471_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13569-016-0053-3","volume":"6","author":"Y Inagaki","year":"2016","unstructured":"Inagaki Y, Hookway E, Williams KA et al (2016) Dendritic and mast cell involvement in the inflammatory response to primary malignant bone tumours. Clin Sarcoma Res 6:13","journal-title":"Clin Sarcoma Res"},{"issue":"3","key":"6471_CR48","doi-asserted-by":"publisher","DOI":"10.4161\/jkst.24053","volume":"2","author":"K Inagaki-Ohara","year":"2013","unstructured":"Inagaki-Ohara K, Kondo T, Ito M, Yoshimura A (2013) SOCS, inflammation, and cancer. JAK-STAT 2(3):e24053","journal-title":"JAK-STAT"},{"key":"6471_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00514","volume":"5","author":"P Italiani","year":"2014","unstructured":"Italiani P, Boraschi D (2014) From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol 5:514","journal-title":"Front Immunol"},{"issue":"2","key":"6471_CR50","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/abt\/tbaa006","volume":"3","author":"AR Jalil","year":"2020","unstructured":"Jalil AR, Andrechak JC, Discher DE (2020) Macrophage checkpoint blockade: results from initial clinical trials, binding analyses, and CD47-SIRP\u03b1 structure-function. Antibody Ther 3(2):80\u201394","journal-title":"Antibody Ther"},{"issue":"15","key":"6471_CR51","doi-asserted-by":"publisher","first-page":"20934","DOI":"10.18632\/oncotarget.8064","volume":"7","author":"XH Jia","year":"2016","unstructured":"Jia XH, Feng GW, Wang ZL et al (2016) Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects. Oncotarget 7(15):20934\u201320944","journal-title":"Oncotarget"},{"issue":"13","key":"6471_CR52","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.7150\/ijbs.60782","volume":"17","author":"X Jia","year":"2021","unstructured":"Jia X, Yan B, Tian X et al (2021) CD47\/SIRP\u03b1 pathway mediates cancer immune escape and immunotherapy. Int J Biol Sci 17(13):3281\u20133287","journal-title":"Int J Biol Sci"},{"key":"6471_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1378647","volume":"14","author":"C Jiang","year":"2024","unstructured":"Jiang C, Sun H, Jiang Z, Tian W, Cang S, Yu J (2024) Targeting the CD47\/SIRP\u03b1 pathway in malignancies: recent progress, difficulties and future perspectives. Front Oncol 14:1378647","journal-title":"Front Oncol"},{"issue":"1","key":"6471_CR54","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12967-020-02348-2","volume":"18","author":"MP Kallis","year":"2020","unstructured":"Kallis MP, Maloney C, Blank B, Soffer SZ, Symons M, Steinberg BM (2020) Pharmacological prevention of surgery-accelerated metastasis in an animal model of osteosarcoma. J Transl Med 18(1):183","journal-title":"J Transl Med"},{"issue":"3","key":"6471_CR55","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1089\/jayao.2016.0078","volume":"6","author":"FC Kelleher","year":"2017","unstructured":"Kelleher FC, O\u2019Sullivan H (2017) Monocytes, macrophages, and osteoclasts in osteosarcoma. J Adolesc Young Adult Oncol 6(3):396\u2013405","journal-title":"J Adolesc Young Adult Oncol"},{"key":"6471_CR56","doi-asserted-by":"crossref","unstructured":"Keremit\u00e7i D, Tuna \u00d6, Houdjedj A, Kazan H, Kaymaz Y (2025) Transcriptional states of lung cancer microenvironment reveal macrophage subtype dynamics linked to disease progression. J Immunol","DOI":"10.1093\/jimmun\/vkaf253"},{"issue":"3","key":"6471_CR57","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","volume":"3","author":"J Kim","year":"2006","unstructured":"Kim J, Tchernyshyov I, Semenza GL, Dang CV (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3(3):177\u2013185","journal-title":"Cell Metab"},{"issue":"3\u20134","key":"6471_CR58","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.phymed.2012.10.016","volume":"20","author":"Y Kimura","year":"2013","unstructured":"Kimura Y, Sumiyoshi M (2013) Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis. Phytomedicine 20(3\u20134):328\u2013336","journal-title":"Phytomedicine"},{"key":"6471_CR59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2014.10.048","volume":"746","author":"Y Kimura","year":"2015","unstructured":"Kimura Y, Sumiyoshi M (2015) Antitumor and antimetastatic actions of dihydroxycoumarins (esculetin or fraxetin) through the inhibition of M2 macrophage differentiation in tumor-associated macrophages and\/or G1 arrest in tumor cells. Eur J Pharmacol 746:115\u2013125","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"6471_CR60","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/01635581.2016.1158295","volume":"68","author":"Y Kimura","year":"2016","unstructured":"Kimura Y, Sumiyoshi M (2016) Resveratrol prevents tumor growth and metastasis by inhibiting lymphangiogenesis and M2 macrophage activation and differentiation in tumor-associated macrophages. Nutr Cancer 68(4):667\u2013678","journal-title":"Nutr Cancer"},{"issue":"2","key":"6471_CR61","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1200\/JCO.1991.9.2.259","volume":"9","author":"ES Kleinerman","year":"1991","unstructured":"Kleinerman ES, Snyder JS, Jaffe N (1991) Influence of chemotherapy administration on monocyte activation by liposomal muramyl tripeptide phosphatidylethanolamine in children with osteosarcoma. J Clin Oncol 9(2):259\u2013267","journal-title":"J Clin Oncol"},{"issue":"8","key":"6471_CR62","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","volume":"38","author":"M Klichinsky","year":"2020","unstructured":"Klichinsky M, Ruella M, Shestova O et al (2020) Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat Biotechnol 38(8):947\u2013953","journal-title":"Nat Biotechnol"},{"key":"6471_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/srep30093","volume":"6","author":"P Koirala","year":"2016","unstructured":"Koirala P, Roth ME, Gill J et al (2016) Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma. Sci Rep 6:30093","journal-title":"Sci Rep"},{"issue":"Pt B","key":"6471_CR64","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.addr.2015.11.009","volume":"99","author":"Y Komohara","year":"2016","unstructured":"Komohara Y, Fujiwara Y, Ohnishi K, Takeya M (2016) Tumor-associated macrophages: potential therapeutic targets for anti-cancer therapy. Adv Drug Deliv Rev 99(Pt B):180\u2013185","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"6471_CR65","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar V, Patel S, Tcyganov E, Gabrilovich DI (2016) The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol 37(3):208\u2013220","journal-title":"Trends Immunol"},{"issue":"5","key":"6471_CR66","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/17460441.2020.1733525","volume":"15","author":"S Kumar","year":"2020","unstructured":"Kumar S, Ramesh A, Kulkarni A (2020) Targeting macrophages: a novel avenue for cancer drug discovery. Expert Opin Drug Discov 15(5):561\u2013574","journal-title":"Expert Opin Drug Discov"},{"issue":"2","key":"6471_CR67","first-page":"121","volume":"14","author":"ID Kurzman","year":"1999","unstructured":"Kurzman ID, Shi F, Vail DM, MacEwen EG (1999) In vitro and in vivo enhancement of canine pulmonary alveolar macrophage cytotoxic activity against canine osteosarcoma cells. Cancer Biother Radiopharm 14(2):121\u2013128","journal-title":"Cancer Biother Radiopharm"},{"key":"6471_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02689","volume":"10","author":"M Lazarova","year":"2019","unstructured":"Lazarova M, Steinle A (2019) Impairment of NKG2D-mediated tumor immunity by TGF-\u03b2. Front Immunol 10:2689","journal-title":"Front Immunol"},{"key":"6471_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102367","author":"T Le","year":"2021","unstructured":"Le T, Su S, Kirshtein A, Shahriyari L (2021) Data-driven mathematical model of osteosarcoma. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13102367","journal-title":"Cancers (Basel)"},{"issue":"2","key":"6471_CR70","first-page":"170","volume":"1835","author":"H Lee","year":"2013","unstructured":"Lee H, Choi H, Ha S, Lee K, Kwon Y (2013) Recruitment of monocytes\/macrophages in different tumor microenvironments. Biochim Biophys Acta 1835(2):170\u2013179","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"6471_CR71","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cell.2008.07.025","volume":"134","author":"MO Li","year":"2008","unstructured":"Li MO, Flavell RA (2008) TGF-beta: a master of all T cell trades. Cell 134(3):392\u2013404","journal-title":"Cell"},{"key":"6471_CR72","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.intimp.2017.01.006","volume":"44","author":"X Li","year":"2017","unstructured":"Li X, Chen Y, Liu X et al (2017a) Tim3\/Gal9 interactions between T cells and monocytes result in an immunosuppressive feedback loop that inhibits Th1 responses in osteosarcoma patients. Int Immunopharmacol 44:153\u2013159","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"6471_CR73","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","volume":"66","author":"X Li","year":"2017","unstructured":"Li X, Yao W, Yuan Y et al (2017b) Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut 66(1):157\u2013167","journal-title":"Gut"},{"key":"6471_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.630355","volume":"9","author":"GQ Li","year":"2021","unstructured":"Li GQ, Wang YK, Zhou H et al (2021) Application of immune infiltration signature and machine learning model in the differential diagnosis and prognosis of bone-related malignancies. Front Cell Dev Biol 9:630355","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"6471_CR75","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1111\/cas.15821","volume":"114","author":"F Li","year":"2023","unstructured":"Li F, Tang H, Luo X et al (2023a) Interaction gene set between osteoclasts and regulatory CD4+ T cells can accurately predict the prognosis of patients with osteosarcoma. Cancer Sci 114(7):3014\u20133026","journal-title":"Cancer Sci"},{"issue":"8","key":"6471_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1386","volume":"13","author":"J Li","year":"2023","unstructured":"Li J, Sun J, Zeng Z et al (2023b) Tumour-associated macrophages in gastric cancer: from function and mechanism to application. Clin Transl Med 13(8):e1386","journal-title":"Clin Transl Med"},{"issue":"1","key":"6471_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-15125-2","volume":"15","author":"Y Li","year":"2025","unstructured":"Li Y, Zou X, Feng X, Xia J, Wu Z, Ma H (2025) Exosomal LncRNA SCAMP1-AS1 enhances osteosarcoma malignancy by regulating the LKB1-AMPK signaling pathway. Sci Rep 15(1):29560","journal-title":"Sci Rep"},{"key":"6471_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1394339","volume":"12","author":"H Liang","year":"2024","unstructured":"Liang H, Cui M, Tu J, Chen X (2024) Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies. Front Cell Dev Biol 12:1394339","journal-title":"Front Cell Dev Biol"},{"key":"6471_CR79","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.fob.2015.08.002","volume":"5","author":"T Liu","year":"2015","unstructured":"Liu T, Fang XC, Ding Z, Sun ZG, Sun LM, Wang YL (2015) Pre-operative lymphocyte-to-monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma. FEBS Open Bio 5:682\u2013687","journal-title":"FEBS Open Bio"},{"issue":"4","key":"6471_CR80","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/CJI.0000000000000122","volume":"39","author":"J Liu","year":"2016","unstructured":"Liu J, Zhang S, Hu Y et al (2016) Targeting PD-1 and Tim-3 pathways to reverse CD8 T-cell exhaustion and enhance ex vivo T-cell responses to autologous dendritic\/tumor vaccines. J Immunother 39(4):171\u2013180","journal-title":"J Immunother"},{"issue":"1","key":"6471_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0381-z","volume":"10","author":"X Liu","year":"2017","unstructured":"Liu X, Kwon H, Li Z, Fu Y (2017) Is CD47 an innate immune checkpoint for tumor evasion. J Hematol Oncol 10(1):12","journal-title":"J Hematol Oncol"},{"issue":"8","key":"6471_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1795-7","volume":"10","author":"T Liu","year":"2019","unstructured":"Liu T, Ma Q, Zhang Y et al (2019) Self-seeding circulating tumor cells promote the proliferation and metastasis of human osteosarcoma by upregulating interleukin-8. Cell Death Dis 10(8):575","journal-title":"Cell Death Dis"},{"issue":"1","key":"6471_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09042-6","volume":"21","author":"R Liu","year":"2021","unstructured":"Liu R, Hu Y, Liu T, Wang Y (2021a) Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer. BMC Cancer 21(1):1345","journal-title":"BMC Cancer"},{"key":"6471_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.709210","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu Y, Feng W, Dai Y et al (2021b) Single-cell transcriptomics reveals the complexity of the tumor microenvironment of treatment-naive osteosarcoma. Front Oncol 11:709210","journal-title":"Front Oncol"},{"key":"6471_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.879288","volume":"12","author":"W Liu","year":"2022","unstructured":"Liu W, Hao Y, Tian X, Jiang J, Qiu Q (2022) The role of NR4A1 in the pathophysiology of osteosarcoma: a comprehensive bioinformatics analysis of the single-cell RNA sequencing dataset. Front Oncol 12:879288","journal-title":"Front Oncol"},{"issue":"1","key":"6471_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05903-3","volume":"22","author":"Y Liu","year":"2024","unstructured":"Liu Y, Xiao L, Yang M et al (2024) CAR-armored-cell therapy in solid tumor treatment. J Transl Med 22(1):1076","journal-title":"J Transl Med"},{"issue":"1","key":"6471_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-65467-8","volume":"16","author":"X Lu","year":"2025","unstructured":"Lu X, Jie X, Xin S et al (2025a) Apatinib plus ifosfamide and etoposide versus ifosfamide and etoposide in patients with advanced osteosarcomas (OAIE\/PKUPH-sarcoma 11): a randomized phase II study. Nat Commun 16(1):10473","journal-title":"Nat Commun"},{"issue":"8","key":"6471_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.110420","volume":"301","author":"X Lu","year":"2025","unstructured":"Lu X, Chen Z, Yi C et al (2025b) An anti-CD47 antibody binds to a distinct epitope in a novel metal ion-dependent manner to minimize cross-linking of red blood cells. J Biol Chem 301(8):110420","journal-title":"J Biol Chem"},{"key":"6471_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.586580","volume":"10","author":"ZW Luo","year":"2020","unstructured":"Luo ZW, Liu PP, Wang ZX, Chen CY, Xie H (2020) Macrophages in osteosarcoma immune microenvironment: implications for immunotherapy. Front Oncol 10:586580","journal-title":"Front Oncol"},{"issue":"1","key":"6471_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01723-z","volume":"22","author":"KM Maalej","year":"2023","unstructured":"Maalej KM, Merhi M, Inchakalody VP et al (2023) CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. Mol Cancer 22(1):20","journal-title":"Mol Cancer"},{"issue":"2","key":"6471_CR91","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","volume":"40","author":"AJ Majmundar","year":"2010","unstructured":"Majmundar AJ, Wong WJ, Simon MC (2010) Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40(2):294\u2013309","journal-title":"Mol Cell"},{"issue":"19","key":"6471_CR92","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1002\/cncr.30724","volume":"123","author":"RG Majzner","year":"2017","unstructured":"Majzner RG, Simon JS, Grosso JF et al (2017) Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues. Cancer 123(19):3807\u20133815","journal-title":"Cancer"},{"issue":"6","key":"6471_CR93","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1158\/1535-7163.MCT-19-0903","volume":"19","author":"C Maloney","year":"2020","unstructured":"Maloney C, Kallis MP, Edelman M et al (2020) Gefitinib inhibits invasion and metastasis of osteosarcoma via inhibition of macrophage receptor interacting serine-threonine kinase 2. Mol Cancer Ther 19(6):1340\u20131350","journal-title":"Mol Cancer Ther"},{"key":"6471_CR94","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","volume":"27","author":"FO Martinez","year":"2009","unstructured":"Martinez FO, Helming L, Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27:451\u2013483","journal-title":"Annu Rev Immunol"},{"key":"6471_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155451","author":"A Mazumdar","year":"2020","unstructured":"Mazumdar A, Urdinez J, Boro A et al (2020) Osteosarcoma-derived extracellular vesicles induce lung fibroblast reprogramming. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21155451","journal-title":"Int J Mol Sci"},{"issue":"4","key":"6471_CR96","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1200\/JCO.2008.14.0095","volume":"26","author":"PA Meyers","year":"2008","unstructured":"Meyers PA, Schwartz CL, Krailo MD et al (2008) Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival\u2013a report from the Children\u2019s Oncology Group. J Clin Oncol 26(4):633\u2013638","journal-title":"J Clin Oncol"},{"issue":"1","key":"6471_CR97","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s41232-025-00390-5","volume":"45","author":"Y Mitsui","year":"2025","unstructured":"Mitsui Y, Satoh T (2025) Functional diversity of disorder-specific macrophages involved in various diseases. Inflamm Regen 45(1):29","journal-title":"Inflamm Regen"},{"issue":"9","key":"6471_CR98","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/cncr.30606","volume":"123","author":"S Miwa","year":"2017","unstructured":"Miwa S, Nishida H, Tanzawa Y et al (2017) Phase 1\/2 study of immunotherapy with dendritic cells pulsed with autologous tumor lysate in patients with refractory bone and soft tissue sarcoma. Cancer 123(9):1576\u20131584","journal-title":"Cancer"},{"key":"6471_CR99","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal Malefyt R, Coffman RL, O\u2019Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683\u2013765","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"6471_CR100","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","volume":"33","author":"SM Morrissey","year":"2021","unstructured":"Morrissey SM, Zhang F, Ding C et al (2021) Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metab 33(10):2040-2058.e10","journal-title":"Cell Metab"},{"issue":"6824","key":"6471_CR101","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A M\u00fcller","year":"2001","unstructured":"M\u00fcller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824):50\u201356","journal-title":"Nature"},{"issue":"1","key":"6471_CR102","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK et al (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41(1):14\u201320","journal-title":"Immunity"},{"issue":"9","key":"6471_CR103","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth N, Wicha MS, Zou W (2017) Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol 17(9):559\u2013572","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"6471_CR104","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1248\/cpb.c16-00844","volume":"65","author":"T Nohara","year":"2017","unstructured":"Nohara T, Fujiwara Y, El-Aasr M et al (2017) Antitumor allium sulfides. Chem Pharm Bull (Tokyo) 65(3):209\u2013217","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"9","key":"6471_CR105","doi-asserted-by":"publisher","first-page":"C569","DOI":"10.1152\/ajpcell.00207.2015","volume":"309","author":"MZ Noman","year":"2015","unstructured":"Noman MZ, Hasmim M, Messai Y et al (2015) Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia. Am J Physiol Cell Physiol 309(9):C569\u2013C579","journal-title":"Am J Physiol Cell Physiol"},{"key":"6471_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080889","author":"S Okada","year":"2019","unstructured":"Okada S, Vaeteewoottacharn K, Kariya R (2019) Application of highly immunocompromised mice for the establishment of patient-derived xenograft (PDX) models. Cells. https:\/\/doi.org\/10.3390\/cells8080889","journal-title":"Cells"},{"issue":"4","key":"6471_CR107","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","volume":"50","author":"W Ouyang","year":"2019","unstructured":"Ouyang W, O\u2019Garra A (2019) IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity 50(4):871\u2013891","journal-title":"Immunity"},{"key":"6471_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-33-27","volume":"33","author":"JHW Pahl","year":"2014","unstructured":"Pahl JHW, Kwappenberg KMC, Varypataki EM et al (2014) Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-\u03b3. J Exp Clin Cancer Res 33:27","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"6471_CR109","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","volume":"41","author":"A Palazon","year":"2014","unstructured":"Palazon A, Goldrath AW, Nizet V, Johnson RS (2014) HIF transcription factors, inflammation, and immunity. Immunity 41(4):518\u2013528","journal-title":"Immunity"},{"key":"6471_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan Y, Yu Y, Wang X, Zhang T (2020) Tumor-associated macrophages in tumor immunity. Front Immunol 11:583084","journal-title":"Front Immunol"},{"issue":"7635","key":"6471_CR111","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual G, Avgustinova A, Mejetta S et al (2017) Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541(7635):41\u201345","journal-title":"Nature"},{"issue":"39","key":"6471_CR112","doi-asserted-by":"publisher","first-page":"18274","DOI":"10.1039\/D4NR02795G","volume":"16","author":"H Patni","year":"2024","unstructured":"Patni H, Chaudhary R, Kumar A (2024) Unleashing nanotechnology to redefine tumor-associated macrophage dynamics and non-coding RNA crosstalk in breast cancer. Nanoscale 16(39):18274\u201318294","journal-title":"Nanoscale"},{"key":"6471_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17162687","author":"G Pennisi","year":"2025","unstructured":"Pennisi G, Valeri F, Burattini B et al (2025) Targeting macrophages in glioblastoma: current therapies and future directions. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers17162687","journal-title":"Cancers (Basel)"},{"issue":"1","key":"6471_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55770-1","volume":"16","author":"S Pierini","year":"2025","unstructured":"Pierini S, Gabbasov R, Oliveira-Nunes MC et al (2025) Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models. Nat Commun 16(1):706","journal-title":"Nat Commun"},{"issue":"2","key":"6471_CR115","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1021\/cbmi.3c00106","volume":"2","author":"ZT Piontkowski","year":"2024","unstructured":"Piontkowski ZT, Hayes DC, McDonald A, Pattison K, Butler KS, Timlin JA (2024) Label-free, noninvasive bone cell classification by hyperspectral confocal raman microscopy. Chem Biomed Imaging 2(2):147\u2013155","journal-title":"Chem Biomed Imaging"},{"issue":"11","key":"6471_CR116","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.tcb.2004.09.016","volume":"14","author":"FJ Pixley","year":"2004","unstructured":"Pixley FJ, Stanley ER (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 14(11):628\u2013638","journal-title":"Trends Cell Biol"},{"issue":"6","key":"6471_CR117","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/JLB.MR0718-269R","volume":"105","author":"I Prager","year":"2019","unstructured":"Prager I, Watzl C (2019) Mechanisms of natural killer cell-mediated cellular cytotoxicity. J Leukoc Biol 105(6):1319\u20131329","journal-title":"J Leukoc Biol"},{"issue":"7","key":"6471_CR118","doi-asserted-by":"publisher","first-page":"687","DOI":"10.18632\/oncotarget.27479","volume":"11","author":"F Punzo","year":"2020","unstructured":"Punzo F, Bellini G, Tortora C et al (2020) Mifamurtide and TAM-like macrophages: effect on proliferation, migration and differentiation of osteosarcoma cells. Oncotarget 11(7):687\u2013698","journal-title":"Oncotarget"},{"issue":"3","key":"6471_CR119","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1158\/1535-7163.MCT-19-1079","volume":"19","author":"RJ Puro","year":"2020","unstructured":"Puro RJ, Bouchlaka MN, Hiebsch RR et al (2020) Development of AO-176, a next-generation humanized anti-CD47 antibody with novel anticancer properties and negligible red blood cell binding. Mol Cancer Ther 19(3):835\u2013846","journal-title":"Mol Cancer Ther"},{"issue":"7355","key":"6471_CR120","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"B Qian","year":"2011","unstructured":"Qian B, Li J, Zhang H et al (2011) CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475(7355):222\u2013225","journal-title":"Nature"},{"issue":"5","key":"6471_CR121","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/carcin\/bgz130","volume":"41","author":"L Raimondi","year":"2020","unstructured":"Raimondi L, De Luca A, Gallo A et al (2020) Osteosarcoma cell-derived exosomes affect tumor microenvironment by specific packaging of microRNAs. Carcinogenesis 41(5):666\u2013677","journal-title":"Carcinogenesis"},{"issue":"1","key":"6471_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-023-01593-3","volume":"21","author":"S Rajan","year":"2023","unstructured":"Rajan S, Franz EM, McAloney CA et al (2023) Osteosarcoma tumors maintain intra-tumoral transcriptional heterogeneity during bone and lung colonization. BMC Biol 21(1):98","journal-title":"BMC Biol"},{"issue":"2","key":"6471_CR123","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1189\/jlb.1MR1016-434RR","volume":"102","author":"S Ran","year":"2017","unstructured":"Ran S, Wilber A (2017) Novel role of immature myeloid cells in formation of new lymphatic vessels associated with inflammation and tumors. J Leukoc Biol 102(2):253\u2013263","journal-title":"J Leukoc Biol"},{"issue":"6","key":"6471_CR124","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ccr.2014.05.016","volume":"25","author":"CH Ries","year":"2014","unstructured":"Ries CH, Cannarile MA, Hoves S et al (2014) Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell 25(6):846\u2013859","journal-title":"Cancer Cell"},{"issue":"11","key":"6471_CR125","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s11864-024-01269-2","volume":"25","author":"MJ Robinson","year":"2024","unstructured":"Robinson MJ, Davis EJ (2024) Neoadjuvant chemotherapy for adults with osteogenic sarcoma. Curr Treat Options Oncol 25(11):1366\u20131373","journal-title":"Curr Treat Options Oncol"},{"issue":"4","key":"6471_CR126","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser EC, Mauri C (2015) Regulatory B cells: origin, phenotype, and function. Immunity 42(4):607\u2013612","journal-title":"Immunity"},{"issue":"11","key":"6471_CR127","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1158\/2326-6066.CIR-21-1075","volume":"10","author":"AR S\u00e1nchez-Paulete","year":"2022","unstructured":"S\u00e1nchez-Paulete AR, Mateus-Tique J, Mollaoglu G et al (2022) Targeting macrophages with CAR T cells delays solid tumor progression and enhances antitumor immunity. Cancer Immunol Res 10(11):1354\u20131369","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"6471_CR128","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1124\/pharmrev.123.000901","volume":"76","author":"A Santiso","year":"2024","unstructured":"Santiso A, Heinemann A, Kargl J (2024) Prostaglandin E2 in the tumor microenvironment, a convoluted affair mediated by EP receptors 2 and 4. Pharmacol Rev 76(3):388\u2013413","journal-title":"Pharmacol Rev"},{"issue":"8","key":"6471_CR129","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/cmi.2017.35","volume":"14","author":"A Sarvaria","year":"2017","unstructured":"Sarvaria A, Madrigal JA, Saudemont A (2017) B cell regulation in cancer and anti-tumor immunity. Cell Mol Immunol 14(8):662\u2013674","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"6471_CR130","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3(10):721\u2013732","journal-title":"Nat Rev Cancer"},{"key":"6471_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1530890","volume":"16","author":"Q Shang","year":"2025","unstructured":"Shang Q, Zhang P, Lei X, Du L, Qu B (2025) Insights into CSF-1\/CSF-1R signaling: the role of macrophage in radiotherapy. Front Immunol 16:1530890","journal-title":"Front Immunol"},{"issue":"10","key":"6471_CR132","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/s41401-019-0262-4","volume":"40","author":"X Shao","year":"2019","unstructured":"Shao X, Xiang S, Chen Y et al (2019) Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells. Acta Pharmacol Sin 40(10):1343\u20131350","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"6471_CR133","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A, Mohammadian S, Vazini H et al (2018) Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 233(9):6425\u20136440","journal-title":"J Cell Physiol"},{"issue":"7","key":"6471_CR134","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nri3857","volume":"15","author":"P Shen","year":"2015","unstructured":"Shen P, Fillatreau S (2015) Antibody-independent functions of B cells: a focus on cytokines. Nat Rev Immunol 15(7):441\u2013451","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"6471_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2026.168176","volume":"1872","author":"L Shu-Jin","year":"2026","unstructured":"Shu-Jin L, Xiao-He W, Ling-Rui L, Lei C, Zhi-Jun S (2026) Leveraging macrophage plasticity for precision-targeted tumor immunotherapy. Biochim Biophys Acta Mol Basis Dis 1872(4):168176","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"6471_CR136","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.4049\/jimmunol.132.4.2105","volume":"132","author":"S Sone","year":"1984","unstructured":"Sone S, Mutsuura S, Ogawara M, Tsubura E (1984) Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes. J Immunol 132(4):2105\u20132110","journal-title":"J Immunol"},{"issue":"7-8","key":"6471_CR137","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.phymed.2015.05.005","volume":"22","author":"M Sumiyoshi","year":"2015","unstructured":"Sumiyoshi M, Taniguchi M, Baba K, Kimura Y (2015) Antitumor and antimetastatic actions of xanthoangelol and 4-hydroxyderricin isolated from Angelica keiskei roots through the inhibited activation and differentiation of M2 macrophages. Phytomedicine 22(7\u20138):759\u2013767","journal-title":"Phytomedicine"},{"issue":"18","key":"6471_CR138","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-3928","volume":"9","author":"CY Sun","year":"2021","unstructured":"Sun CY, Zhang Z, Tao L et al (2021) T cell exhaustion drives osteosarcoma pathogenesis. Ann Transl Med 9(18):1447","journal-title":"Ann Transl Med"},{"key":"6471_CR139","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17172770","author":"K Takabatake","year":"2025","unstructured":"Takabatake K, Tianyan P, Arashima T et al (2025) Refining the role of tumor-associated macrophages in oral squamous cell carcinoma. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers17172770","journal-title":"Cancers (Basel)"},{"issue":"28","key":"6471_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207518","volume":"10","author":"F Tang","year":"2023","unstructured":"Tang F, Tie Y, Lan TX et al (2023) Surgical treatment of osteosarcoma induced distant pre-metastatic niche in lung to facilitate the colonization of circulating tumor cells. Adv Sci 10(28):e2207518","journal-title":"Adv Sci"},{"issue":"2","key":"6471_CR141","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05577-2","volume":"150","author":"H Tang","year":"2024","unstructured":"Tang H, Xie J, Du YX, Tan ZJ, Liang ZT (2024) Osteosarcoma neutrophil extracellular trap network-associated gene recurrence and metastasis model. J Cancer Res Clin Oncol 150(2):48","journal-title":"J Cancer Res Clin Oncol"},{"key":"6471_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.884196","volume":"12","author":"YR Thaker","year":"2022","unstructured":"Thaker YR, Rivera I, Pedros C et al (2022) A novel affinity engineered anti-CD47 antibody with improved therapeutic index that preserves erythrocytes and normal immune cells. Front Oncol 12:884196","journal-title":"Front Oncol"},{"key":"6471_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113672","author":"Y Tsubakihara","year":"2018","unstructured":"Tsubakihara Y, Moustakas A (2018) Epithelial-mesenchymal transition and metastasis under the control of transforming growth factor \u03b2. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19113672","journal-title":"Int J Mol Sci"},{"key":"6471_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.911368","volume":"14","author":"J Tu","year":"2023","unstructured":"Tu J, Wang D, Zheng X, Liu B (2023) Single-cell RNA datasets and bulk RNA datasets analysis demonstrated C1Q+ tumor-associated macrophage as a major and antitumor immune cell population in osteosarcoma. Front Immunol 14:911368","journal-title":"Front Immunol"},{"key":"6471_CR145","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-1-60327-360-2_13","volume":"605","author":"N van Rooijen","year":"2010","unstructured":"van Rooijen N, Hendrikx E (2010) Liposomes for specific depletion of macrophages from organs and tissues. Methods Mol Biol 605:189\u2013203","journal-title":"Methods Mol Biol"},{"key":"6471_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24010009","author":"FJ van Dalen","year":"2018","unstructured":"van Dalen FJ, van Stevendaal MHME, Fennemann FL, Verdoes M, Ilina O (2018) Molecular repolarisation of tumour-associated macrophages. Molecules. https:\/\/doi.org\/10.3390\/molecules24010009","journal-title":"Molecules"},{"issue":"1","key":"6471_CR147","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L (2019) Macrophages and metabolism in the tumor microenvironment. Cell Metab 30(1):36\u201350","journal-title":"Cell Metab"},{"issue":"11","key":"6471_CR148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027690","volume":"6","author":"JD Waight","year":"2011","unstructured":"Waight JD, Hu Q, Miller A, Liu S, Abrams SI (2011) Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS ONE 6(11):e27690","journal-title":"PLoS ONE"},{"issue":"5","key":"6471_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201801986","volume":"6","author":"S Wang","year":"2019","unstructured":"Wang S, Wang Z, Yu G et al (2019) Tumor-specific drug release and reactive oxygen species generation for cancer chemo\/chemodynamic combination therapy. Adv Sci 6(5):1801986","journal-title":"Adv Sci"},{"issue":"2","key":"6471_CR150","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-019-0769-3","volume":"115","author":"Z Wang","year":"2020","unstructured":"Wang Z, Lu YL, Zhao WT et al (2020) Distinct origins and functions of cardiac orthotopic macrophages. Basic Res Cardiol 115(2):8","journal-title":"Basic Res Cardiol"},{"key":"6471_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.619195","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang Z, Guan D, Huo J et al (2021) IL-10 enhances human natural killer cell effector functions via metabolic reprogramming regulated by mTORC1 signaling. Front Immunol 12:619195","journal-title":"Front Immunol"},{"key":"6471_CR152","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.881022","volume":"12","author":"B Wang","year":"2022","unstructured":"Wang B, Wang X, Li P et al (2022) Osteosarcoma cell-derived exosomal ELFN1-AS1 mediates macrophage M2 polarization via sponging miR-138-5p and miR-1291 to promote the tumorgenesis of osteosarcoma. Front Oncol 12:881022","journal-title":"Front Oncol"},{"issue":"1","key":"6471_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-023-00245-0","volume":"11","author":"T Wang","year":"2023","unstructured":"Wang T, Wang L, Zhang L, Long Y, Zhang Y, Hou Z (2023) Single-cell RNA sequencing in orthopedic research. Bone Res 11(1):10","journal-title":"Bone Res"},{"key":"6471_CR154","first-page":"1","volume":"53","author":"Q Wang","year":"2025","unstructured":"Wang Q, Huang M, Guo JJ (2025) From cells to clinic: single-cell transcriptomics shaping the future of orthopedics. J Orthop Transl 53:1\u201311","journal-title":"J Orthop Transl"},{"issue":"1","key":"6471_CR155","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47412-1","volume":"13","author":"DL Welch","year":"2023","unstructured":"Welch DL, Fridley BL, Cen L et al (2023) Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy. Sci Rep 13(1):20125","journal-title":"Sci Rep"},{"issue":"17","key":"6471_CR156","doi-asserted-by":"publisher","first-page":"6662","DOI":"10.1073\/pnas.1121623109","volume":"109","author":"SB Willingham","year":"2012","unstructured":"Willingham SB, Volkmer JP, Gentles AJ et al (2012) The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A 109(17):6662\u20136667","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6471_CR157","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1747677","volume":"9","author":"K Wolf-Dennen","year":"2020","unstructured":"Wolf-Dennen K, Gordon N, Kleinerman ES (2020) Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions. Oncoimmunology 9(1):1747677","journal-title":"Oncoimmunology"},{"key":"6471_CR158","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11040564","author":"L Wu","year":"2019","unstructured":"Wu L, Saxena S, Awaji M, Singh RK (2019) Tumor-associated neutrophils in cancer: going pro. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11040564","journal-title":"Cancers (Basel)"},{"issue":"8","key":"6471_CR159","doi-asserted-by":"publisher","first-page":"7611","DOI":"10.1007\/s13277-014-2005-y","volume":"35","author":"Q Xiao","year":"2014","unstructured":"Xiao Q, Zhang X, Wu Y, Yang Y (2014) Inhibition of macrophage polarization prohibits growth of human osteosarcoma. Tumour Biol 35(8):7611\u20137616","journal-title":"Tumour Biol"},{"key":"6471_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109235","volume":"112","author":"X Xiong","year":"2022","unstructured":"Xiong X, Xie X, Wang Z, Zhang Y, Wang L (2022) Tumor-associated macrophages in lymphoma: From mechanisms to therapy. Int Immunopharmacol 112:109235","journal-title":"Int Immunopharmacol"},{"key":"6471_CR161","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.974996","volume":"13","author":"C Xu","year":"2022","unstructured":"Xu C, Xiao M, Li X et al (2022) Origin, activation, and targeted therapy of glioma-associated macrophages. Front Immunol 13:974996","journal-title":"Front Immunol"},{"issue":"7","key":"6471_CR162","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1158\/0008-5472.CAN-23-1307","volume":"84","author":"Y Xu","year":"2024","unstructured":"Xu Y, Deng C, Chen H et al (2024) Osteosarcoma cells secrete CXCL14 that activates integrin \u03b111\u03b21 on fibroblasts to form a lung metastatic niche. Cancer Res 84(7):994\u20131012","journal-title":"Cancer Res"},{"issue":"1","key":"6471_CR163","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02325-5","volume":"10","author":"J Xu","year":"2025","unstructured":"Xu J, Ding L, Mei J et al (2025) Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Signal Transduct Target Ther 10(1):268","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"6471_CR164","doi-asserted-by":"publisher","first-page":"e658","DOI":"10.1002\/mco2.658","volume":"5","author":"L Yan","year":"2020","unstructured":"Yan L, Wang J, Cai X et al (2020) Macrophage plasticity: signaling pathways, tissue repair, and regeneration. MedComm 5(8):e658","journal-title":"MedComm"},{"issue":"1","key":"6471_CR165","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0430-2","volume":"10","author":"L Yang","year":"2017","unstructured":"Yang L, Zhang Y (2017) Tumor-associated macrophages: from basic research to clinical application. J Hematol Oncol 10(1):58","journal-title":"J Hematol Oncol"},{"issue":"2","key":"6471_CR166","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/jjco\/hyl137","volume":"37","author":"Q Yang","year":"2007","unstructured":"Yang Q, Zeng B, Dong Y, Shi Z, Jiang Z, Huang J (2007) Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome. Jpn J Clin Oncol 37(2):127\u2013134","journal-title":"Jpn J Clin Oncol"},{"key":"6471_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215887","volume":"547","author":"W Yang","year":"2022","unstructured":"Yang W, Fan T, Chongqi T, Francis H, Zhenfeng D, Li M (2022) Immune checkpoints in osteosarcoma: recent advances and therapeutic potential. Cancer Lett 547:215887","journal-title":"Cancer Lett"},{"issue":"1","key":"6471_CR168","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97090-0","volume":"11","author":"Z Yao","year":"2021","unstructured":"Yao Z, Tan Z, Yang J et al (2021) Prognostic nomogram for predicting 5-year overall survival in Chinese patients with high-grade osteosarcoma. Sci Rep 11(1):17728","journal-title":"Sci Rep"},{"key":"6471_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1217669","volume":"14","author":"H Ying","year":"2023","unstructured":"Ying H, Li ZQ, Li MP, Liu WC (2023) Metabolism and senescence in the immune microenvironment of osteosarcoma: focus on new therapeutic strategies. Front Endocrinol (Lausanne) 14:1217669","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"6471_CR170","first-page":"165","volume":"72","author":"A Yoshida","year":"2018","unstructured":"Yoshida A, Fujiwara T, Uotani K et al (2018) Clinical and functional significance of intracellular and extracellular microRNA-25-3p in osteosarcoma. Acta Med Okayama 72(2):165\u2013174","journal-title":"Acta Med Okayama"},{"issue":"3","key":"6471_CR171","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201932RR","volume":"37","author":"L Yu","year":"2023","unstructured":"Yu L, Zhang Y, Liu C et al (2023) Heterogeneity of macrophages in atherosclerosis revealed by single-cell RNA sequencing. FASEB J 37(3):e22810","journal-title":"FASEB J"},{"issue":"19","key":"6471_CR172","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1158\/1078-0432.CCR-11-0482","volume":"17","author":"MR Zaidi","year":"2011","unstructured":"Zaidi MR, Merlino G (2011) The two faces of interferon-\u03b3 in cancer. Clin Cancer Res 17(19):6118\u20136124","journal-title":"Clin Cancer Res"},{"issue":"9","key":"6471_CR173","doi-asserted-by":"publisher","first-page":"6832","DOI":"10.1002\/jcp.26436","volume":"233","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Fu L, Liang Y et al (2018) Exosomes originating from MSCs stimulated with TGF-\u03b2 and IFN-\u03b3 promote Treg differentiation. J Cell Physiol 233(9):6832\u20136840","journal-title":"J Cell Physiol"},{"issue":"5","key":"6471_CR174","first-page":"2049","volume":"42","author":"ML Zhang","year":"2019","unstructured":"Zhang ML, Chen L, Li YJ, Kong DL (2019) PD\u2011L1\/PD\u20111 axis serves an important role in natural killer cell\u2011induced cytotoxicity in osteosarcoma. Oncol Rep 42(5):2049\u20132056","journal-title":"Oncol Rep"},{"issue":"4","key":"6471_CR175","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.18632\/aging.102824","volume":"12","author":"C Zhang","year":"2020","unstructured":"Zhang C, Zheng JH, Lin ZH et al (2020a) Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma. Aging (Albany NY) 12(4):3486\u20133501","journal-title":"Aging (Albany NY)"},{"key":"6471_CR176","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00018","volume":"11","author":"W Zhang","year":"2020","unstructured":"Zhang W, Huang Q, Xiao W et al (2020b) Advances in anti-tumor treatments targeting the CD47\/SIRP\u03b1 axis. Front Immunol 11:18","journal-title":"Front Immunol"},{"key":"6471_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.109844","volume":"188","author":"W Zhang","year":"2025","unstructured":"Zhang W, Xie Y, Chen F, Xie B, Yin Z (2025) Development and validation of a neutrophil extracellular traps-related gene signature for lower-grade gliomas. Comput Biol Med 188:109844","journal-title":"Comput Biol Med"},{"key":"6471_CR178","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1769847","volume":"17","author":"K Zhang","year":"2026","unstructured":"Zhang K, Wang Z, He J et al (2026) Advances in T cell-based immunotherapy for osteosarcoma. Front Immunol 17:1769847","journal-title":"Front Immunol"},{"key":"6471_CR179","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jconrel.2021.05.036","volume":"335","author":"M Zhao","year":"2021","unstructured":"Zhao M, Li J, Liu J et al (2021) Charge-switchable nanoparticles enhance cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction. J Control Release 335:320\u2013332","journal-title":"J Control Release"},{"issue":"1","key":"6471_CR180","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-018-0780-x","volume":"9","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Wang G, Chen R, Hua Y, Cai Z (2018) Mesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications. Stem Cell Res Ther 9(1):22","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"6471_CR181","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1158\/2326-6066.CIR-16-0259","volume":"5","author":"Q Zhou","year":"2017","unstructured":"Zhou Q, Xian M, Xiang S et al (2017) All-trans retinoic acid prevents osteosarcoma metastasis by inhibiting M2 polarization of tumor-associated macrophages. Cancer Immunol Res 5(7):547\u2013559","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"6471_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20059-6","volume":"11","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Yang D, Yang Q et al (2020) Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. Nat Commun 11(1):6322","journal-title":"Nat Commun"},{"key":"6471_CR183","doi-asserted-by":"crossref","unstructured":"Zhou TA, Hsu HP, Tu YH, et al. (2022) Thymic macrophages consist of two populations with distinct localization and origin. Elife 11","DOI":"10.7554\/eLife.75148"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06471-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-026-06471-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06471-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:01:54Z","timestamp":1776117714000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-026-06471-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":183,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6471"],"URL":"https:\/\/doi.org\/10.1007\/s00432-026-06471-3","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"88"}}